Antitumor activity of 5-substituted 3-(1'-anilinoethylidene)pyrrolidine-2, 4-dione.
D000814:Aniline Compounds / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001412:Bacillus subtilis / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor; D004926:Escherichia coli / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental; D011760:Pyrrolidinones / Q000494:pharmacology*; D051381:Rats; D012517:Sarcoma, Yoshida; D013210:Staphylococcus / Q000187:drug effects; D013237:Stereoisomerism
D000814:Aniline Compounds; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D011760:Pyrrolidinones